The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study
Authors:
- WECARE Study Collaborative GroupWGWECARE Study Collaborative Group
- Julia A. KnightJKJulia A. Knight
- Kristina M. BlackmoreKBKristina M. Blackmore
- Jing FanJFJing Fan
- Kathleen E. MaloneKMKathleen E. Malone
- Esther M. JohnEJEsther M. John
- Charles F. LynchCLCharles F. Lynch
- Celine M. VachonCVCeline M. Vachon
- Leslie BernsteinLBLeslie Bernstein
- Jennifer D. BrooksJBJennifer D. Brooks
- Anne S. ReinerARAnne S. Reiner
- Xiaolin LiangXLXiaolin Liang
Open Access
- 22 March 2018
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 20 (1) , 23
Abstract
Mammographic density (MD) is an established predictor of risk of a first breast cancer, but the relationship of MD to contralateral breast cancer (CBC) risk is not clear, including the roles of age, mammogram timing, and change with treatment. Multivariable prediction models for CBC risk are needed and MD could contribute to these. We conducted a case-control study of MD and CBC risk in phase II of the WECARE study where cases had a CBC diagnosed ≥ 2 years after first diagnosis at age <55 years and controls had unilateral breast cancer (UBC) with similar follow-up time. We retrieved film mammograms of the unaffected breast from two time points, prior to/at the time of the first diagnosis (253 CBC cases, 269 UBC controls) and ≥ 6 months up to 48 months following the first diagnosis (333 CBC cases, 377 UBC controls). Mammograms were digitized and percent MD (%MD) was measured using the thresholding program Cumulus. Odds ratios (OR) and 95% confidence intervals (CI) for association between %MD and CBC, adjusted for age, treatment, and other factors related to CBC, were estimated using logistic regression. Linear regression was used to estimate the association between treatment modality and change in %MD in 467 women with mammograms at both time points. For %MD assessed following diagnosis, there was a statistically significant trend of increasing CBC with increasing %MD (p = 0.03). Lower density (<25%) was associated with reduced risk of CBC compared to 25 to < 50% density (OR 0.69, 95% CI 0.49, 0.98). Similar, but weaker, associations were noted for %MD measurements prior to/at diagnosis. The relationship appeared strongest in women aged < 45 years and non-existent in women aged 50 to 54 years. A decrease of ≥ 10% in %MD between first and second mammogram was associated marginally with reduced risk of CBC (OR 0.63, 95% CI 0.40, 1.01) compared to change of <10%. Both tamoxifen and chemotherapy were associated with statistically significant 3% decreases in %MD (p < 0.01). Post-diagnosis measures of %MD may be useful to include in CBC risk prediction models with consideration of age at diagnosis. Chemotherapy is associated with reductions in %MD, similar to tamoxifen.Keywords
Funding Information
- National Institutes of Health (U01 CA83178, R01 CA97397, R01 CA129639, R01 CA114236, P30 CA008748, R01 CA168339)
This publication has 28 references indexed in Scilit:
- Mammographic breast density is associated with the development of contralateral breast cancerCancer, 2017
- A model for individualized risk prediction of contralateral breast cancerBreast Cancer Research and Treatment, 2016
- Impact of type of full-field digital image on mammographic density assessment and breast cancer risk estimation: a case-control studyBreast Cancer Research, 2016
- Digital mammographic density and breast cancer risk: a case–control study of six alternative density assessment methodsBreast Cancer Research, 2014
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Review of risk factors for the development of contralateral breast cancerThe American Journal of Surgery, 2013
- The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortalityCancer Epidemiology, 2012
- Mammographic Density and Risk of Second Breast Cancer after Ductal Carcinoma In situCancer Epidemiology, Biomarkers & Prevention, 2010
- Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancerBreast Cancer Research and Treatment, 2010
- Epidemiology of contralateral breast cancer.1999